Management of Biventricular Dysfunction with Low Pressure Severe Tricuspid Regurgitation

Initial Medical Management

The American College of Cardiology recommends initiating aggressive diuretic therapy with loop diuretics as first-line treatment for patients with biventricular dysfunction and low pressure severe tricuspid regurgitation, while carefully assessing whether the patient has severe RV or LV dysfunction that would preclude surgical intervention 1, 2
Loop diuretics are the cornerstone of initial management to relieve systemic and hepatic congestion, though their use may be limited by worsening low-flow syndrome in the setting of biventricular dysfunction 1, 3
The American Heart Association suggests considering adding aldosterone antagonists for additional volume management and to address TR-related volume overload, although this is based on guidelines from Praxis Medical Insights 2, 4

The European Society of Cardiology states that the presence of severe RV or LV dysfunction is a critical contraindication to isolated tricuspid valve surgery, making this assessment paramount 5, 6, 7
Severe right ventricular dysfunction, severe left ventricular dysfunction, and severe pulmonary vascular disease or pulmonary hypertension are key factors that preclude surgery 5, 6, 7

The European Heart Journal indicates that surgery is indicated for symptomatic patients with severe isolated primary TR WITHOUT severe right ventricular dysfunction (Class I, Level C) 8, 5, 6, 7
TV repair with a prosthetic ring is the first-line surgical approach when intervention is indicated, preferable to replacement due to better postoperative outcomes 8, 2, 4

The European Heart Journal suggests that for inoperable patients with severe TR and biventricular dysfunction, transcatheter treatment may be considered at specialized heart valve centers (Class IIb, Level C) 8, 4

The European Heart Journal warns that delaying intervention until irreversible RV dysfunction develops is a common pitfall, and while patients often respond well to diuretic therapy initially, this can create false reassurance and delay definitive treatment 5, 6
Avoid aggressive diuresis that precipitates hypotension and worsening renal function in low-output states, as both hypovolemia and hypervolemia can worsen the hemodynamic condition 1, 3, 4

The European Heart Journal notes that given the "low pressure" descriptor, this suggests either low pulmonary artery pressures or low systemic pressures from biventricular failure, with the latter being unfavorable 5, 6, 7, 8
The realistic management pathway for most patients with established biventricular dysfunction and severe TR is aggressive medical management with diuretics and GDMT, evaluation at a specialized heart valve center for potential transcatheter intervention, and palliative care discussions if neither surgical nor transcatheter options are feasible 2, 4, 8